Drug Manufacturers - General

The Drug Manufacturers - General industry has a total of 18 stocks, with a combined market cap of $2,952.33 billion, total revenue of $603.35 billion and a weighted average PE ratio of 34.28.

Market Cap
2,952.33B
Revenue
603.35B
Profits
86.13B
PE Ratio
34.28
Profit Margin
14.28%
Dividend Yield
2.03%

18 Stocks

No. Symbol Company Name Market Cap % Change Volume Revenue
1LLYEli Lilly and Company763.34B2.55%3,528,13035.93B
2JNJJohnson & Johnson363.99B-0.02%3,770,44981.80B
3MRKMerck & Co., Inc.331.19B-0.18%6,243,14661.40B
4ABBVAbbVie Inc.287.71B-0.99%2,507,78554.40B
5AZNAstraZeneca PLC245.50B2.68%7,533,70847.61B
6NVSNovartis AG201.21B-882,06149.92B
7AMGNAmgen Inc.168.90B0.10%1,703,94029.53B
8PFEPfizer Inc.161.84B0.11%21,977,18255.09B
9SNYSanofi122.66B1.09%716,63751.60B
10GSKGSK plc90.65B-0.29%3,474,85239.41B
11BMYBristol-Myers Squibb Company85.69B-2.51%14,372,81945.53B
12GILDGilead Sciences, Inc.83.83B-0.90%4,546,48727.45B
13BIIBBiogen Inc.33.15B-1.68%760,8019.66B
14GRFSGrifols, S.A.6.48B-0.13%802,4217.32B
15OGNOrganon & Co.5.62B0.37%1,023,8466.35B
16AMRNAmarin Corporation plc368.27M1.90%481,940277.46M
17SCLXScilex Holding Company201.12M-8.26%1,193,20147.05M
18MIRAMIRA Pharmaceuticals, Inc.15.08M20.00%546,395-